Malta - English - Medicines Authority

glaxo wellcome uk limited - guaifenesin; triprolidine hydrochloride; pseudoephedrine hydrochloride - oral solution - guaifenesin 100 mg/5ml; triprolidine hydrochloride 1.25 mg/5ml; pseudoephedrine hydrochloride 30 mg/5ml - nasal preparations

Malta - English - Medicines Authority

glaxo wellcome uk limited - triprolidine hydrochloride; guaifenesin; pseudoephedrine hydrochloride - oral solution - triprolidine hydrochloride 1.25 mg/5ml; guaifenesin 100 mg/5ml; pseudoephedrine hydrochloride 30 mg/5ml - nasal preparations

Malta - English - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - guaifenesin, triprolidine hydrochloride, pseudoephedrine hydrochloride - oral solution - guaifenesin 100 mg/5ml triprolidine hydrochloride 1.25 mg/5ml pseudoephedrine hydrochloride 30 mg/5ml - nasal preparations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - triprolidine hydrochloride; pseudoephedrine hydrochloride; guaifenesin - oral solution - 250microgram/1ml ; 6mg/1ml ; 20mg/1ml

Malta - English - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - triprolidine hydrochloride, guaifenesin, pseudoephedrine hydrochloride - oral solution - triprolidine hydrochloride 1.25 mg/5ml guaifenesin 100 mg/5ml pseudoephedrine hydrochloride 30 mg/5ml - nasal preparations

Canada - English - Health Canada

teva canada limited - triprolidine hydrochloride; pseudoephedrine hydrochloride; guaifenesin; codeine phosphate - syrup - 2mg; 30mg; 100mg; 10mg - triprolidine hydrochloride 2mg; pseudoephedrine hydrochloride 30mg; guaifenesin 100mg; codeine phosphate 10mg - antitussives

Canada - English - Health Canada

glaxosmithkline inc - triprolidine hydrochloride; pseudoephedrine hydrochloride; guaifenesin; codeine phosphate - syrup - 2mg; 30mg; 100mg; 10mg - triprolidine hydrochloride 2mg; pseudoephedrine hydrochloride 30mg; guaifenesin 100mg; codeine phosphate 10mg - antitussives

Ireland - English - HPRA (Health Products Regulatory Authority)

johnson & johnson (ireland) limited - pseudoephedrine hydrochloride; guaifenesin - syrup - 30 mg/5ml + 100 mg/5ml - sympathomimetics; pseudoephedrine, combinations

United States - English - NLM (National Library of Medicine)

wockhardt usa, inc. - triprolidine hydrochloride (unii: yan7r5l890) (triprolidine - unii:2l8t9s52qm), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520) - syrup - 1.25 mg in 5 ml - pseudodine™ c cough syrup is indicated for temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. pseudodine™ c cough syrup is contraindicated under the following conditions: this drug should not be used in newborn or premature infants. antihistamines should not be used to treat lower respiratory tract symptoms, including asthma. (1) codeine phosphate or other narcotics; (2) triprolidine hydrochloride or other antihistamines of similar chemical structure; or (3) sympathomimetic amines, including pseudoephedrine. sympathomimetic amines are contraindicated in patients with severe hypertension, severe coronary artery disease and in patients on monoamine oxidase (mao) inhibitor therapy (see precautions, drug interactions ). like other medications containing a narcotic, pseudodine™ c cough syrup is controlled by the drug enforcement administration. it is classified under schedule v. codeine can produce drug dependence of the morphine typ

United States - English - NLM (National Library of Medicine)

sti pharma llc - triprolidine hydrochloride (unii: yan7r5l890) (triprolidine - unii:2l8t9s52qm), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - triprolidine hydrochloride 1.25 mg in 5 ml - triacin-c is indicated for temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. triacin-c is contraindicated under the following conditions: codeine sulfate is contraindicated for postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy. this drug should not be used in newborn or premature infants. antihistamines should not be used to treat lower respiratory tract symptoms, including asthma. hypersensitivity to (1) codeine phosphate or other narcotics; (2) triprolidine hydrochloride or other antihistamines of similar chemical structure; or (3) sympathomimetic amines, including pseudoephedrine. sympathomimetic amines are contraindicated in patients with severe hypertension, severe coronary artery disease and in patients on monoamine oxidase (mao) inhibitor therapy (see precautions - drug interactions ). like other medications containing a narcotic, triacin-c is controlled by the drug enforcemen